HOME >> MEDICINE >> NEWS
The influence of money on medical science

JAMA Editor-in-Chief Catherine D. DeAngelis, M.D., M.P.H., issues editorial on "The Influence of Money on Medical Science"

Because of the importance of the issue of the influence of money in science and in light of recent incidents involving authors failure to disclose all of their potential conflicts of interest to JAMA, Dr. DeAngelis has written an editorial on the subject which will be posted online at www.JAMA.com Monday, August 7, 2006.

" we have made no attempt to conceal the episodes of failure to disclose in a simple correction published in JAMA, and we will continue this approach until it becomes unnecessary," Dr. DeAngelis writes. "While our efforts to educate authors about the importance of full disclosure of relevant conflicts of interest and to enforce compliance with tightened rules has not always been received as warmly as we might hope, we do see a silver lining even in the harshest scrutiny. The intensity of public discussion is invaluable not only for raising the visibility of JAMA's requirements, but also for increasing awareness of the potential influence of money in science and for increasing appreciation for the role that full disclosure of potential conflicts of interest plays in ensuring that physicians and patients can properly interpret, and more importantly, trust, what they read in JAMA." (doi: 10.1001/jama.296.8.jed60051)


'"/>

Contact: Jim Michalski
312-464-5785
JAMA and Archives Journals
7-Aug-2006


Page: 1

Related medicine news :

1. Young childrens taste preferences may be influenced by fast-food branding
2. The appetite-regulating peptide leptin influences alcohol craving for some alcoholics
3. Smoking influences Crohns disease
4. Extended family ties influenced evacuation decisions during Hurricane Katrina
5. Drug company sales visits influenced doctors, study finds
6. Drug reps use friendship to influence doctors
7. The influence of the menstrual cycle on the female brain
8. Erectile dysfunction influenced by race and ethnicity
9. Patients requests for antidepressants can influence physician evaluation of depression
10. How much influence do medical publications have on your doctor? A great deal, says new SLU research
11. Free drug samples influence prescribing, say one in three doctors

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The influence money medical science

(Date:8/31/2015)... ... August 31, 2015 , ... For 12 years, since ... acknowledged September 26th as Mesothelioma Awareness Day . On this day, and in ... several ways of becoming involved and helping the cause. , “One of the ways ...
(Date:8/31/2015)... ... , ... MeYou Health ®, a social well-being company and wholly owned ... by including an in-app step tracker. , Walkadoo is a pedometer-based walking program ... than broadly assign every Walkadoo member 10,000 steps a day (as is typical for ...
(Date:8/31/2015)... ... ... It’s a lot like coming home. Life-long Fox Valley resident James Holbrook has ... on the job, he’s run into residents of the retirement community who he’s known ... living in such a wonderful place,” he said. GreenFields, which is sponsored by Friendship ...
(Date:8/31/2015)... ... August 31, 2015 , ... PartnerTech hosted ... Owners and provided a tour of their North American facility following the S.M.A.R.T ... international companies expanding business in the U.S. , The PartnerTech Inc. North ...
(Date:8/31/2015)... Dallas, TX (PRWEB) , ... August 31, 2015 ... ... Coalition’s EARLIER Awareness campaign, TAKE ACTION. NOT CHANCES. (SM) will be featured on ... building. The eye-catching campaign image is designed to inspire and promote earlier awareness ...
Breaking Medicine News(10 mins):Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:PartnerTech Supports Economic Growth as Host 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 3
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , ... SNY ; EURONEXT: SAN) and the life sciences team ... improve care and outcomes for people with type 1 ... diabetes treatments and devices with Google,s expertise in analytics, ... will explore how to improve diabetes care by developing ...
(Date:8/31/2015)... 31, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... field of regenerative medicine, today announced that the ... Chicago -based Rush University Medical Center in ... escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) in ... cervical spinal cord injury (SCI). This represents the ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
Cached News: